Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TRANZYME INC | 2,999,320 | reported | 06 Apr 2011 | tx 9+3,002,286−15,328,549 |
| CLARUS THERAPEUTICS INC | 3,528 | reported | 20 Apr 2022 | tx 6−3,752,912 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Apr 2022 | SALE | CLARUS THERAPEUTICS INC | 2,061,685 | 2.53 USD | |
| 20 Apr 2022 | SALE | CLARUS THERAPEUTICS INC | 5,722 | 2.53 USD | |
| 20 Apr 2022 | SALE | CLARUS THERAPEUTICS INC | 7,585 | 2.53 USD | |
| 20 Apr 2022 | SALE | CLARUS THERAPEUTICS INC | 1,164 | 2.53 USD | |
| 20 Apr 2022 | SALE | CLARUS THERAPEUTICS INC | 13,630 | 2.53 USD | |
| 20 Apr 2022 | SALE | CLARUS THERAPEUTICS INC | 1,663,126 | 2.53 USD | |
| 06 Apr 2011 | CONVERSION | TRANZYME INC | 2,103,623 | — | |
| 06 Apr 2011 | CONVERSION | TRANZYME INC | 78,175 | — | |
| 06 Apr 2011 | PURCHASE | TRANZYME INC | 2,966 | 4.00 USD | |
| 06 Apr 2011 | PURCHASE | TRANZYME INC | 794,966 | 4.00 USD | |
| 06 Apr 2011 | PURCHASE | TRANZYME INC | 14,568 | 4.00 USD | |
| 06 Apr 2011 | CONVERSION | TRANZYME INC | 7,988 | — | |
| 06 Apr 2011 | CONVERSION | TRANZYME INC | 14,725,374 | 0.00 USD | deriv |
| 06 Apr 2011 | CONVERSION | TRANZYME INC | 547,229 | 0.00 USD | deriv |
| 06 Apr 2011 | CONVERSION | TRANZYME INC | 55,946 | 0.00 USD | deriv |